Treating relapsed and refractory disease: CAR T-cell therapy
This recorded session from Solving Kids' Cancer UK's 2025 Neuroblastoma Parent Symposium delves into promising strategies for managing relapsed and refractory neuroblastoma, focusing specifically on CAR T-cell therapy. Prof Anderson and Dr Francesca del Bufalo explain how this innovative immunotherapy works, recent advances, and its potential impact for children with neuroblastoma.
Looking for something else?
-
Need to speak with someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to see how we can support you.
-
Refractory neuroblastomaFind all the information on refractory neuroblastoma in one place.
-
Relapsed neuroblastomaFind all the information on relapsed neuroblastoma in one place.
Related videos
-
VideoIf treatment doesn't go to plan
Explores care for relapsed and refractory neuroblastoma, alongside reflections on hope from a childhood cancer advocate.
-
VideoRelapse strategies and trials
Explores treatment strategies and clinical trials for relapsed neuroblastoma, including targeted and immunotherapies.
-
VideoTreating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.